The distribution of schedule 5 and 6 medication to theatre presents to
be much more chalenging than it seems. As a pharmacist, we are
ethically obliged to contol the distribution and make sure that the
schedule register always balances with what is happening. The problem
lies within sharing of vials or ampoules between patients, the
distribution of drugs between theatres within main theatre, and
balancing what has really been given to patient and what is written up
in schedule book in the end of the day. Any one who has a suggesting/
best practise to controlling drugs in a theatre situation
John Smith ® - 05 Feb 2007 14:19 GMT
> The distribution of schedule 5 and 6 medication to theatre presents to
> be much more chalenging than it seems. As a pharmacist, we are
[quoted text clipped - 5 lines]
> in schedule book in the end of the day. Any one who has a suggesting/
> best practise to controlling drugs in a theatre situation
That is why we use only unit dose scheduled drugs and a Pyxis system for
delivery.
Linda - 11 Feb 2007 22:37 GMT
On Jan 29, 9:56�am, "michelle" <michelle.stan...@mediclinic.co.za>
wrote:
> The distribution of schedule 5 and 6 medication to theatre presents to
> be much more chalenging than it seems. As a pharmacist, we are
[quoted text clipped - 5 lines]
> in schedule book in the end of the day. Any one who has a suggesting/
> best practise to controlling drugs in a theatre situation
I work for a surgery center and have the same problems. We have
changed our policies to not allow sharing of vials between patients-
it's just too hard to keep track of. Of course we use unit dose
vials, but for example if two patients needed just 50mcg of Fentanyl,
the anesthesiologist used to split between. Now we have the
anesthesiologist give 1ml to the patient and waste 1ml with a witness
(now THAT'S a problem for us-having them counter-sign waste, doesn't
seem to get done but 60% of the time). Luckily, all the schedule 2
drugs we use are very inexpensive, so the extra cost is minimal.